37300-21-3O=S(=O)(O)O[C@@H]1[C@@H](OS(=O)(=O)O)[C@H](O[C@@H]2CO[C@@H](O)[C@H](OS(=O)(=O)O)[C@H]2OS(=O)(=O)O)OC[C@H]1OFCCNSUIJIOOXEZ-SJYYZXOBSA-N[(2R,3R,4S,5R)-2-Hydroxy-5-{[(2S,3R,4S,5R)-5-hydroxy-3,4-bis(sulfooxy)oxan-2-yl]oxy}-4-(sulfooxy)oxan-3-yl]oxidanesulfonic acid is a glycoside.
Pentosan polysulfate is a polymer of xylose hydrogen sulfate and contains two sulfate groups per carbohydrate monomer. It binds Fibroblast growth factors (FGFs) as well as other heparin-binding growth factors. It has been shown to interact also with the heparin-binding site of FGFR-1. It inhibits the growth of SW13 adrenocortical cells transfected with FGF-4 and tumorigenicity of MCF-7 breast carcinoma cells transfected with FGF-1 or FGF-4.
F59P8B75R4
PENTOSAN POLYSULFATE
Established Pharmacologic Class [EPC] - Glycosaminoglycan
Chemical Structure [CS] - Glycosaminoglycans
Pentosan polysulfate is a Glycosaminoglycan.
HistoryPentosan polysulfate sodium (Elmiron) was synthesized at Baker Norton Pharmaceuticals in the early 1980s as a heparin analogue for interstitial cystitis; after orphan designation (1985) and compassionate use (1986–1995) it received FDA approval on 26 September 1996 under an NDA that listed no individually named inventors, and its efficacy was later questioned when the first controlled trial (Nickel, 2014) proved negative.
No reaction records under the current filter.
Loading…
37300-21-3CHEMBL4073796CHEBI:184555DefinitionChEBI: [(2R,3R,4S,5R)-2-Hydroxy-5-{[(2S,3R,4S,5R)-5-hydroxy-3,4-bis(sulfooxy)oxan-2-yl]oxy}-4-(sulfooxy)oxan-3-yl]oxidanesulfonic acid is a glycoside.